Journal article · 2023 · Open access

Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination

Jianqin Wan, Lulu Ren, Xiaoyan Li, Shasha He, Yang Fu, Peirong Xu, Fanchao Meng, Shiyun Xian, Kanyi Pu, Hangxiang Wang

Proceedings of the National Academy of Sciences, 120(8), e2210385120 · Published 14 February 2023 · DOI 10.1073/pnas.2210385120

Open full textCite this paper

In brief

“Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination” is a 2023 journal article by Jianqin Wan and 9 co-authors, published in Proceedings of the National Academy of Sciences. OpenAlex counts 70 citations as of 21 November 2026, which puts it in the top 3% of works published in 2023 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Proceedings of the National Academy of Sciences.

Citations
70
Most cited in
2024 (26)
Field-weighted impact
4.37
References
52
Authors
10

Abstract

Immunotherapy holds great promise for the treatment of aggressive and metastatic cancers; however, currently available immunotherapeutics, such as immune checkpoint blockade, benefit only a small subset of patients. A photoactivatable toll-like receptor 7/8 (TLR7/8) nanoagonist (PNA) system that imparts near-infrared (NIR) light-induced immunogenic cell death (ICD) in dying tumor cells in synchrony with the spontaneous release of a potent immunoadjuvant is developed here. The PNA consists of polymer-derived proimmunoadjuvants ligated via a reactive oxygen species (ROS)-cleavable linker and polymer-derived photosensitizers, which are further encapsulated in amphiphilic matrices for systemic injection. In particular, conjugation of the TLR7/8 agonist resiquimod to biodegradable macromolecular moieties with different molecular weights enabled pharmacokinetic tuning of small-molecule agonists and optimized delivery efficiency in mice. Upon NIR photoirradiation, PNA effectively generated ROS not only to ablate tumors and induce the ICD cascade but also to trigger the on-demand release of TLR agonists. In several preclinical cancer models, intravenous PNA administration followed by NIR tumor irradiation resulted in remarkable tumor regression and suppressed postsurgical tumor recurrence and metastasis. Furthermore, this treatment profoundly shifted the tumor immune landscape to a tumoricidal one, eliciting robust tumor-specific T cell priming in vivo. This work highlights a simple and cost-effective approach to generate in situ cancer vaccines for synergistic photodynamic immunotherapy of metastatic cancers.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Wan, J., Ren, L., Li, X., He, S., Fu, Y., Xu, P., Meng, F., Xian, S., Pu, K., & Wang, H. (2023). Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination. Proceedings of the National Academy of Sciences, 120(8), e2210385120. https://doi.org/10.1073/pnas.2210385120

MLA 9

Wan, Jianqin, et al. “Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination.” Proceedings of the National Academy of Sciences, vol. 120, no. 8, 2023, p. e2210385120. https://doi.org/10.1073/pnas.2210385120.

Chicago

Wan, Jianqin, Lulu Ren, Xiaoyan Li, Shasha He, Yang Fu, Peirong Xu, Fanchao Meng, Shiyun Xian, Kanyi Pu, and Hangxiang Wang. 2023. “Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination.” Proceedings of the National Academy of Sciences 120 (8): e2210385120. https://doi.org/10.1073/pnas.2210385120.

Harvard

Wan, J. et al. (2023) ‘Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination’, Proceedings of the National Academy of Sciences, 120(8), p. e2210385120. doi:10.1073/pnas.2210385120.

IEEE

J. Wan et al., “Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination,” Proceedings of the National Academy of Sciences, vol. 120, no. 8, p. e2210385120, 2023, doi: 10.1073/pnas.2210385120.

BibTeX

@article{wan2023photoactivatable,
  title     = {{Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination}},
  author    = {Wan, Jianqin and Ren, Lulu and Li, Xiaoyan and He, Shasha and Fu, Yang and Xu, Peirong and Meng, Fanchao and Xian, Shiyun and Pu, Kanyi and Wang, Hangxiang},
  journal   = {Proceedings of the National Academy of Sciences},
  year      = {2023},
  volume    = {120},
  number    = {8},
  pages     = {e2210385120},
  doi       = {10.1073/pnas.2210385120},
  url       = {https://doi.org/10.1073/pnas.2210385120}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202355
20242626
20252424
20261515

Its field-weighted citation impact is 4.37: it has been cited 4.37 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics

  • TLR7/8 agonist
  • resiquimod
  • immunogenic cell death
  • photosensitizers
  • tumor immunology
  • T cell priming
  • metastatic cancer

Work with this paper

Most-cited papers in Engineering

All highly cited Engineering papers

Questions about this paper

How do I cite this paper in APA style?

Wan, J., Ren, L., Li, X., He, S., Fu, Y., Xu, P., Meng, F., Xian, S., Pu, K., & Wang, H. (2023). Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination. Proceedings of the National Academy of Sciences, 120(8), e2210385120. https://doi.org/10.1073/pnas.2210385120

How many times has this paper been cited?

70 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Proceedings of the National Academy of Sciences: sign in and open the full text from this page.

Who wrote this paper?

Jianqin Wan, Lulu Ren, Xiaoyan Li, Shasha He, Yang Fu, Peirong Xu, Fanchao Meng, Shiyun Xian, Kanyi Pu, Hangxiang Wang.

What is the DOI of this paper?

10.1073/pnas.2210385120, permanently at https://doi.org/10.1073/pnas.2210385120. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.